Fidelity International’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-49,907
| Closed | -$888K | – | 978 |
|
|
2024
Q2 | $888K | Buy |
49,907
+3,407
| +7% | +$60.6K | ﹤0.01% | 725 |
|
|
2024
Q1 | $707K | Buy |
46,500
+3,274
| +8% | +$49.8K | ﹤0.01% | 740 |
|
|
2023
Q4 | $738K | Buy |
+43,226
| New | +$738K | ﹤0.01% | 722 |
|
|
2023
Q3 | – | Sell |
-114,412
| Closed | -$2.84M | – | 848 |
|
|
2023
Q2 | $2.84M | Buy |
114,412
+5,375
| +5% | +$134K | ﹤0.01% | 610 |
|
|
2023
Q1 | $1.64M | Buy |
+109,037
| New | +$1.64M | ﹤0.01% | 680 |
|
|
2021
Q4 | – | Sell |
-170,707
| Closed | -$5.68M | – | 855 |
|
|
2021
Q3 | $5.68M | Sell |
170,707
-6,656
| -4% | -$222K | 0.01% | 585 |
|
|
2021
Q2 | $6.88M | Buy |
177,363
+32,842
| +23% | +$1.27M | 0.01% | 603 |
|
|
2021
Q1 | $6.97M | Buy |
+144,521
| New | +$6.97M | 0.01% | 564 |
|